This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Should You Continue to Retain ABT Stock in Your Portfolio Now?
by Zacks Equity Research
Abbott's robust strength in Core Diagnostics and EPD businesses should continue to benefit in the upcoming quarters.
ABTPositive Net Change BSXPositive Net Change VCYTNegative Net Change TMDXNegative Net Change
medical medical-devices
Butterfly Network's Stock Surges on iQ3 Device Launch in Europe
by Zacks Equity Research
Shares of BFLY gain almost 27% following the announcement of the launch of its latest handheld ultrasound device, Butterfly iQ3, in Europe.
BSXPositive Net Change UHSPositive Net Change APYXPositive Net Change BFLYPositive Net Change
medical medical-devices
HealthEquity Stock Rises on Q2 Earnings and Revenue Beat
by Zacks Equity Research
HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change HQYPositive Net Change
medical medical-devices
AngioDynamics Stock Falls Despite CE Mark for Auryon System
by Zacks Equity Research
ANGO's Auryon Atherectomy System earns CE Mark, which expands its European market reach and enhances PAD treatment with advanced laser technology.
ANGONegative Net Change DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change
medical medical-devices
Buy These 3 Medical Info Systems Stocks to Capitalize on GenAI Boom
by Urmimala Biswas
Zacks Medical Info Systems industry stocks like Inspire Medical Systems, Clover Health Investments and CareCloud are expected to gain from the GenAI wave.
INSPPositive Net Change CLOVPositive Net Change CCLDNegative Net Change
medical medical-devices smart-health
Crown Holdings (CCK)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CCKPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
by Zacks Equity Research
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
BSXPositive Net Change UHSPositive Net Change CAHPositive Net Change APYXPositive Net Change
medical medical-devices
Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump
by Zacks Equity Research
EMBC's shares close higher following FDA clearance for its disposable patch pump for insulin delivery, expanding the target market with its availability for type 2 diabetes.
BSXPositive Net Change UHSPositive Net Change APYXPositive Net Change EMBCPositive Net Change
medical medical-devices
Should You Consider Retaining ZBH Stock in Your Portfolio Now?
by Zacks Equity Research
Zimmer Biomet's robust efforts to expand the Knee business and a gradually stabilizing musculoskeletal market appear promising.
BSXPositive Net Change ZBHPositive Net Change VCYTNegative Net Change TMDXNegative Net Change
medical medical-devices
EW Stock Dips Following the Divestiture of Critical Care Wing
by Zacks Equity Research
Edwards completes the sale of its Critical Care operations and announces a $1 billion share repurchase program.
BDXPositive Net Change EWPositive Net Change AXGNPositive Net Change EXASPositive Net Change
medical medical-devices
Should You Continue to Retain PODD Stock in Your Portfolio Now?
by Zacks Equity Research
Insulet's Omnipod 5 is set to drive growth in the upcoming quarters. Meanwhile, the stock is facing challenges due to economic uncertainties.
BSXPositive Net Change PODDNegative Net Change VCYTNegative Net Change TMDXNegative Net Change
medical medical-devices
Top Medical Stocks to Hedge Against the September Effect
by Shaun Pruitt
Often sought out for defensive protection amid heightened market volatility, medical stocks may be of interest to investors in September which has historically been the most challenging month for stocks.
LLYPositive Net Change DVAPositive Net Change HCAPositive Net Change
earnings hospitals investing large-cap medical medical-devices pharmaceuticals stock-performance value-stocks volatility
Greenville Center to Boost CAH Stock's at-Home Solution Business
by Zacks Equity Research
Cardinal Health announces the opening of its new distribution center in Greenville to support its at-Home Solutions business.
DGXNegative Net Change UHSPositive Net Change CAHPositive Net Change ABMPositive Net Change
medical medical-devices
AdvanSix (ASIX) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ASIXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Femasys Shares Rise on CE Mark & Canada Approval for FemVue MINI
by Zacks Equity Research
FEMY's eco-friendly FemVue MINI receives CE Mark and Health Canada approval, advancing sustainable fallopian tube assessment technology in Europe and Canada.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change FEMYNegative Net Change
medical medical-devices
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
by Zacks Equity Research
QDEL's strong product portfolio raises optimism about the stock.
BSXPositive Net Change UHSPositive Net Change QDELPositive Net Change APYXPositive Net Change
medical medical-devices
EW Stock to Benefit From Favorable RHEIA Trial Data on TAVI
by Zacks Equity Research
Edwards' first all-female TAVI Trial demonstrates favorable outcomes for women receiving Edwards valves.
EWPositive Net Change AXGNPositive Net Change EXASPositive Net Change SIBNPositive Net Change
medical medical-devices
Alerus (ALRS)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ALRSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Delcath Systems Stock Gains on Positive CHEMOSAT Melanoma Data
by Zacks Equity Research
DCTH's study of the CHEMOSAT Hepatic Delivery System shows that the device significantly boosts survival rates in uveal melanoma patients with liver metastases, outperforming systemic therapies.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change DCTHPositive Net Change
medical medical-devices
DaVita Rallies 44% Year to Date: What's Driving the Stock?
by Zacks Equity Research
DVA's shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
DGXNegative Net Change UHSPositive Net Change DVAPositive Net Change ABMPositive Net Change
medical medical-devices
Should You Consider Retaining Bruker Stock in Your Portfolio Now?
by Zacks Equity Research
BRKR's robust growth potential across its major segments is encouraging. Yet, macro woes and competitive pressure can pose challenges.
BSXPositive Net Change BRKRPositive Net Change VCYTNegative Net Change TMDXNegative Net Change
medical medical-devices
QuidelOrtho Expands in Infectious Disease Testing With New FDA Nod
by Zacks Equity Research
QDEL announces the FDA's clearance for its VITROS syphilis assay, which boosts the company's infectious disease testing portfolio.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change QDELPositive Net Change
medical medical-devices
Catalent's Stock Gains on Q4 Earnings Beat, Gross Margin Up
by Zacks Equity Research
CTLT's solid segmental results led to an encouraging fiscal fourth-quarter performance, driving up share prices in after-hours trading.
BSXPositive Net Change DGXNegative Net Change DVAPositive Net Change CTLTNegative Net Change
earnings medical medical-devices
iRhythm Technologies Launches Zio Monitoring Across Europe
by Zacks Equity Research
IRTC launches Zio monitor in Austria, Netherlands, Spain and Switzerland, which offers 14-day continuous ECG monitoring, enhancing arrhythmia diagnosis and patient care.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change IRTCNegative Net Change
medical medical-devices
NexPoint (NREF)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
NREFPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines